Mitzi Rubin, MD
Family Medicine · Marietta, GANPI 1154403582
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $63,450 of the $102,821 with a category attached, or 61.7%. Lilly USA, LLC accounts for 81.0% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $46,406, more than ten times the $4,098 reported in 2019. Among family medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 436 payments — averaging $235.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$83K
- Boehringer Ingelheim$13K
- Eli Lilly$2K
- Novo Nordisk$2K
- Biohaven Pharmaceuticals, Inc.$1K
- AbbVie$380
- plus $1K from 19 others
What the payments were for
- Consulting fees$21,53021%
- Speaking & faculty fees$63,45062%
- Travel & lodging$10,71310%
- Food & beverage$7,0967%
- Education$320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 242 | $83,301 |
| Boehringer Ingelheim | 16 | $13,003 |
| Eli Lilly | 2 | $1,950 |
| Novo Nordisk | 86 | $1,766 |
| Biohaven Pharmaceuticals, Inc. | 7 | $1,297 |
| AbbVie(2 entities) | 27 | $380 |
| Currax Pharmaceuticals LLC | 12 | $186 |
| AstraZeneca | 6 | $180 |
| Amgen | 9 | $155 |
| Astellas Pharma US Inc | 7 | $102 |
| Dexcom, Inc. | 4 | $89 |
| Inspire Medical Systems, Inc. | 1 | $78 |
| Vivus LLC | 3 | $59 |
| Kvk-tech, Inc. | 1 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Echosens North America, Inc. | 1 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $26 |
| Merck | 2 | $25 |
| Rhythm Pharmaceuticals, Inc. | 1 | $24 |
| Bayer | 1 | $24 |
| Abbott | 1 | $22 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$102,821 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 580 | $688,737 |
| MounjaroTirzepatide | 384 | $432,653 |
| WegovySemaglutide | 205 | $286,980 |
| JardianceEmpagliflozin | 48 | $68,811 |
| TrulicityDulaglutide | 45 | $49,108 |
| FarxigaDapagliflozin Propanediol | 38 | $32,769 |
| RybelsusSemaglutide | 27 | $31,617 |
| Naltrexone Hcl | 57 | $1,478 |
| Ondansetron OdtOndansetron | 77 | $1,011 |
| Metformin Hcl | 199 | $968 |
| Bupropion XlBupropion Hcl | 21 | $863 |
| Rosuvastatin Calcium | 11 | $310 |
| Metformin Hcl ErMetformin Hcl | 47 | $309 |
| Levothyroxine Sodium | 25 | $196 |
| Topiramate | 40 | $130 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy, Rybelsus | $1,766 | $1,007,334812 claims |
| Lilly USA, LLCMounjaro, Trulicity | $83,301 | $481,761429 claims |
| Boehringer IngelheimJardiance | $13,003 | $68,81148 claims |
| AstraZenecaFarxiga | $180 | $32,76938 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Marietta
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
- Elmore AlexanderStone Mountain$155K
- Bantwal BaligaColumbus$115K
- Avril CampbellFort Benning$108K
- Mark TannerAtlanta$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.